Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19-Related Illness

Abstract Following the initial report of the outbreak of the SARS-CoV-2 virus by the Chinese government on December 31, 2019, several institution-based analyses described marked coagulation activation ─ in particular, greatly elevated D-dimer levels ─ in association with the systemic inflammatory response in patients hospitalized with COVID-19 Autopsy studies have identified macrovascular pulmonary artery thrombosis/embolism, microvascular pulmonary thrombosis and deep venous thrombosis of the limbs and other sites